NORMSEQ: a tool for evaluation, selection and visualization of RNA-Seq normalization methods
Nucleic Acids Research · 2023
DOI: 10.1093/nar/gkad429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Chantal Scheepbouwer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Cancer Center Amsterdam, Amsterdam University Medical Center (UMC) location Vrije Universiteit Amsterdam, Amsterdam 1081H…. Hauptthemen laut MEDLINE: Gene Expression Profiling, RNA-Seq, Software. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stichting Cancer Center Amsterdam, TKI-Health Holland, Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
RNA-sequencing has become one of the most used high-throughput approaches to gain knowledge about the expression of all different RNA subpopulations. However, technical artifacts, either introduced during library preparation and/or data analysis, can influence the detected RNA expression levels. A critical step, especially in large and low input datasets or studies, is data normalization, which aims at eliminating the variability in data that is not related to biology. Many normalization methods have been developed, each of them relying on different assumptions, making the selection of the appropriate normalization strategy key to preserve biological information. To address this, we developed NormSeq, a free web-server tool to systematically assess the performance of normalization methods in a given dataset. A key feature of NormSeq is the implementation of information gain to guide the selection of the best normalization method, which is crucial to eliminate or at least reduce non-biological variability. Altogether, NormSeq provides an easy-to-use platform to explore different aspects of gene expression data with a special focus on data normalization to help researchers, even without bioinformatics expertise, to obtain reliable biological inference from their data. NormSeq is freely available at: https://arn.ugr.es/normSeq.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Cancer Center Amsterdam, Amsterdam University Medical Center (UMC) location Vrije Universiteit Amsterdam, Amsterdam 1081HV, The Netherlands.
- Cancer Center Amsterdam, Cancer Biology, Amsterdam, The Netherlands.
- Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam 1081HV, The Netherlands.
- Genetics Genetics Department, Faculty of Science, Universidad de Granada, Campus de Fuentenueva s/n, 18071, Granada, Spain.
- Bioinformatics Laboratory, Biomedical Research Centre (CIBM), Biotechnology Institute, PTS, Avda. del Conocimiento s/n, 18100 Granada, Spain.
- Excellence Research Unit "Modeling Nature" (MNat), University of Granada, Spain.
ORCID-Profile: Chantal Scheepbouwer, Michael Hackenberg, Alan Gerber, Michiel Pegtel, Cristina Gómez-Martín
Förderung
- Stichting Cancer Center Amsterdam
- TKI-Health Holland
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
Scheepbouwer, C., Hackenberg, M., van Eijndhoven, M. A. J., Gerber, A., Pegtel, M., & Gómez-Martín, C. (2023). NORMSEQ: a tool for evaluation, selection and visualization of RNA-Seq normalization methods. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad429
Vancouver
Scheepbouwer C, Hackenberg M, van Eijndhoven MAJ, Gerber A, Pegtel M, Gómez-Martín C. NORMSEQ: a tool for evaluation, selection and visualization of RNA-Seq normalization methods. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad429
BibTeX
@article{Scheepbouwer2023,
author = {Scheepbouwer, Chantal and Hackenberg, Michael and van Eijndhoven, Monique A J and Gerber, Alan and Pegtel, Michiel and Gómez-Martín, Cristina},
title = {NORMSEQ: a tool for evaluation, selection and visualization of RNA-Seq normalization methods},
journal = {Nucleic Acids Research},
year = {2023},
doi = {10.1093/nar/gkad429}
}
EUVIMED